145 related articles for article (PubMed ID: 34655183)
1. Point Mutations at gyrA and gyrB Genes of Levofloxacin Resistant Helicobacter pylori Strains and Dual Resistance with Clarithromycin.
Ziver-Sarp T; Yuksel-Mayda P; Saribas S; Demiryas S; Gareayaghi N; Ergin S; Tasci I; Ozbey D; Bal K; Erzin Y; Akkus S; Bahar-Tokman H; Demirci M; Tufan-Kocak B; Kocazeybek B
Clin Lab; 2021 Oct; 67(10):. PubMed ID: 34655183
[TBL] [Abstract][Full Text] [Related]
2. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
[TBL] [Abstract][Full Text] [Related]
3. Point Mutations at
López-Gasca M; Peña J; García-Amado MA; Michelangeli F; Contreras M
Am J Trop Med Hyg; 2018 Apr; 98(4):1051-1055. PubMed ID: 29405113
[TBL] [Abstract][Full Text] [Related]
4. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.
Miyachi H; Miki I; Aoyama N; Shirasaka D; Matsumoto Y; Toyoda M; Mitani T; Morita Y; Tamura T; Kinoshita S; Okano Y; Kumagai S; Kasuga M
Helicobacter; 2006 Aug; 11(4):243-9. PubMed ID: 16882327
[TBL] [Abstract][Full Text] [Related]
5. Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.
Seck A; Burucoa C; Dia D; Mbengue M; Onambele M; Raymond J; Breurec S
Ann Clin Microbiol Antimicrob; 2013 Jan; 12():3. PubMed ID: 23298145
[TBL] [Abstract][Full Text] [Related]
6. High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam.
Phan TN; Santona A; Tran VH; Tran TN; Le VA; Cappuccinelli P; Rubino S; Paglietti B
Int J Antimicrob Agents; 2015 Mar; 45(3):244-8. PubMed ID: 25499186
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.
Cambau E; Allerheiligen V; Coulon C; Corbel C; Lascols C; Deforges L; Soussy CJ; Delchier JC; Megraud F
J Clin Microbiol; 2009 Nov; 47(11):3600-7. PubMed ID: 19759218
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.
Rimbara E; Noguchi N; Kawai T; Sasatsu M
Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin-resistant Helicobacter pylori in Hong Kong.
Lee CC; Lee VW; Chan FK; Ling TK
Chemotherapy; 2008; 54(1):50-3. PubMed ID: 18073471
[TBL] [Abstract][Full Text] [Related]
10. The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori.
Vianna JS; Ramis IB; Ramos DF; Gastal OL; Silva RAD; Gonçalves CV; Silva PEAD
Rev Inst Med Trop Sao Paulo; 2018; 60():e25. PubMed ID: 29972462
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City.
Zerbetto De Palma G; Mendiondo N; Wonaga A; Viola L; Ibarra D; Campitelli E; Salim N; Corti R; Goldman C; Catalano M
Microb Drug Resist; 2017 Apr; 23(3):351-358. PubMed ID: 27391421
[TBL] [Abstract][Full Text] [Related]
12. Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance.
Hamza D; Elhelw R; Elhariri M; Ragab E
Microb Pathog; 2018 Oct; 123():330-338. PubMed ID: 30031039
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization and Mutational Analysis of Clarithromycin- and Levofloxacin-Resistance Genes in
Šamanić I; Dadić B; Sanader Maršić Ž; Dželalija M; Maravić A; Kalinić H; Vrebalov Cindro P; Šundov Ž; Tonkić M; Tonkić A; Vuković J
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834008
[TBL] [Abstract][Full Text] [Related]
14. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.
Wang LH; Cheng H; Hu FL; Li J
World J Gastroenterol; 2010 May; 16(18):2272-7. PubMed ID: 20458765
[TBL] [Abstract][Full Text] [Related]
15. Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
Chang WL; Kao CY; Wu CT; Huang AH; Wu JJ; Yang HB; Cheng HC; Sheu BS
Helicobacter; 2012 Jun; 17(3):210-5. PubMed ID: 22515359
[TBL] [Abstract][Full Text] [Related]
16. Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies.
Liou JM; Chang CY; Sheng WH; Wang YC; Chen MJ; Lee YC; Hung HW; Chian H; Chang SC; Wu MS; Lin JT
Antimicrob Agents Chemother; 2011 Mar; 55(3):1123-9. PubMed ID: 21189342
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a TaqMan-MGB probe multiplex real-time PCR system for one-step levofloxacin and clarithromycin resistant Helicobacter pylori detection.
Zhao Y; Li Y; Luan Z; Ma C; Yang L; Zhang W; Shi C
J Microbiol Methods; 2022 Jan; 192():106393. PubMed ID: 34919971
[TBL] [Abstract][Full Text] [Related]
18. Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin.
Lyu T; Cheung KS; Deng Z; Ni L; Chen C; Wu J; Leung WK; Seto WK
Helicobacter; 2023 Aug; 28(4):e12972. PubMed ID: 36965192
[TBL] [Abstract][Full Text] [Related]
19. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
Chung JW; Lee GH; Jeong JY; Lee SM; Jung JH; Choi KD; Song HJ; Jung HY; Kim JH
J Gastroenterol Hepatol; 2012 Mar; 27(3):493-7. PubMed ID: 21793912
[TBL] [Abstract][Full Text] [Related]
20. Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for
Miftahussurur M; Cruz M; Subsomwong P; Jiménez Abreu JA; Hosking C; Nagashima H; Akada J; Yamaoka Y
Am J Trop Med Hyg; 2017 May; 96(5):1050-1059. PubMed ID: 28193745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
